About

A small company, built to a research standard.

AxwenBio, Inc. was founded in Massachusetts in 2026. The company works only in the United States.

The company has two lines of work. The first is research and development: an innovative peptide therapeutics program for age-related disease, now in its design stage. The second is Axelle, an online platform for prescription medicines for women, operated with independent physicians and licensed partner pharmacies.

The two lines are run the same way. Claims stay narrow, and each one is tied to evidence. A plan is described as a plan, work under way as work under way. What is not yet known is said to be not yet known.

We publish our reasoning as we go. The Insights series sets out the scientific questions the research program is built on.